New study suggests that high-dose hormone treatment might reduce risk for PTSD

Oct 22, 2008

Cortisol helps our bodies cope with stress, but what about its effects on the brain? A new study by Cohen and colleagues, appearing in the October 15th issue of Biological Psychiatry, suggests that the answer to this question is complex.

In an animal model of posttraumatic stress disorder (PTSD), high doses of a cortisol-related substance, corticosterone, prevented negative consequences of stress exposure, including increased startle response and behavioral freezing when exposed to reminders of the stress. However, low-dose corticosterone potentiated these responses. This finding suggests that corticosterone levels may influence both vulnerability and resilience in a dose-dependent manner through its involvement in memory processes.

One of the complexities in understanding PTSD is the context-dependency of adaptation. In some situations, for example following a car accident in an otherwise secure community, one objective of treatment is to restore a sense of normalcy and control of one's life. Within this context, the high-dose corticosterone would seem to be the indicated treatment. However, one could imagine scenarios where hypervigilance and heightened emotional reactivity could be adaptive, perhaps in a combat zone. In that case, the lower and more typical corticosterone levels might help soldiers adapt to the continuing risks of combat. But, people do not spend their lives in a single context. "In the case of helping soldiers adjust to the stress of war, we have to think both short-term and long-term, to help soldiers adjust to combat, but also to help them return from combat to resume peacetime life. Thus, we need further guidance from animal research about how to help soldiers adjust flexibly across contexts, from the battlefield to the breakfast table," as explained by John H. Krystal, M.D., Editor of Biological Psychiatry and affiliated with both Yale University School of Medicine and the VA Connecticut Healthcare System.

Corresponding author Dr. Hagit Cohen concludes that, "single high-dose corticosteroid treatment may thus be worthy of clinical investigation as a possible avenue for early pharmacotherapeutic intervention in the acute phase, aimed at prevention of chronic stress-related disorders, such as PTSD. In this sense, it brings treatment of PTSD to a new era – an era of secondary prevention."

The article is "Early Post-Stressor Intervention with High-Dose Corticosterone Attenuates Posttraumatic Stress Response in an Animal Model of Posttraumatic Stress Disorder" by Hagit Cohen, et at. The article appears in Biological Psychiatry, Volume 64, Issue 8 (October 15, 2008).

Source: Elsevier

Explore further: Funding for pulmonary rehabilitation study in East Africa

add to favorites email to friend print save as pdf

Related Stories

Down with jet lag

Jun 23, 2010

Journeys across several time zones make our internal body clocks go haywire. We feel exhausted and tense, and our sleep pattern is out of synch. As scientists at the Max Planck Institute for Biophysical Chemistry ...

Abusive mothering aggravates the impact of stress hormones

Jun 21, 2010

In a new Biological Psychiatry article, Dr. Regina Sullivan and colleagues have dissected the behavior of mother rats and their infant pups, modeling nurturing by stroking and abuse with electric shock. In this animal model ...

Biological link established between tumors and depression

May 18, 2009

In a study that could help explain the connections between depression and cancer, researchers at the University of Chicago have used an animal model to find, for the first time, a biological link between tumors and negative ...

Easing the stress of trauma

Dec 01, 2008

Post-traumatic stress disorder (PTSD) affects as many as one in five of all Americans who survive a harrowing experience like rape, assault, war or terrorism. It has emotionally paralyzed survivors of 9/11 and broken up survivors' ...

Recommended for you

Researchers gain new insights into hypothyroidism

4 hours ago

An international research team led by physician-scientists at Rush University Medical Center has gained new insights into hypothyroidism - a condition affecting about 10 million people in the U.S. - that may lead to new treatment ...

Liberia closes Ebola centre at epicentre of outbreak

7 hours ago

Liberia's president on Monday announced the closure of an Ebola treatment facility which lay at the epicentre of the virus's worst outbreak in history, as the disease's spread has slowed in the country.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.